Report Description

Saudi Arabia over the counter (OTC) drugs market is bound to experience impressive growth with anticipated CAGR in the forecast period, 2023-2027, on account of rapidly increasing concerns over the non-affordable branded pharmaceuticals. Moreover, rising awareness and rising health concerns among the population are also driving the market growth in the upcoming five years. Additionally, the cost of OTC drugs plays a major role in the consumer inclination toward over counter drugs. The market is heavily affected by the high costs of the branded and prescription drugs that make the consumers look for proper means, and the overall cost for the doctor consultation, prescription preparation, etc., raises the cost of drugs may folds, whereas over the counter drugs are way affordable. Furthermore, consumers are intuitively into self-diagnosis, and the treatment drugs are often available as an over counter drug. The ailments and health issues like mild fever, pain, and generic health issues like obesity, high blood pressure, etc., are further enunciating the consumer’s choice of over the counter drugs on prescription drugs. These factors are aggressively supporting the exponential growth of the Saudi Arabia over the counter (OTC) drugs market in the next five years.

The Saudi Arabia over the counter (OTC) drugs market is segmented by product, route of administration, dosage form, distributional channel, competitional landscape, and regional distribution. Based on product, the market is further bifurcated into cough, cold, and flu; vitamins, minerals, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. Vitamins, minerals, and supplements (VMS) are anticipated to hold the largest revenue shares of the market and assert their dominance over the market on account of rapidly increasing demands from health-conscious consumers. Consumers are actively inclined toward building their physique, healthy diets, and compensating the health nutrients through a maintained dosage of vitamins, minerals, and supplements. Moreover, Cough, cold, and flu category, over the counter (OTC) drugs are expected to register the fastest growing CAGR on the grounds of recent pandemic conditions. The market is expected to grow since patients suffering from COVID-19 are rapidly increasing, and major symptoms of viral infection are cough, cold, and flu.

A partial list of market players in Saudi Arabia over the counter (OTC) drugs market includes Pfizer Saudi Limited, Sanofi Saudi Arabia, GlaxoSmithKline Saudi Arabia Limited, Gulf Pharmaceutical Industries (PSC), Tabuk Pharmaceutical Manufacturing Co., Jamjoom Pharmaceuticals Co, Reckitt Benckiser (Arabia) FZE, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), among others. These market players hold larger shares of the market than the new market players. With the evolving technology, it is appropriate to say that the effective research and development of technologically advanced instruments and methods to satisfy consumer demands would support the market growth and benefit the market players as well as the consumers. New market players may focus on the research and development to provide such products and services that satisfy the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Objective of the Study:

  • To analyze the historical growth of the market size of Saudi Arabia over the counter (OTC) Drugs market from 2017 to 2020.
  • To estimate and forecast the market size of Saudi Arabia over the counter (OTC) drugs market from 2021 to 2027 and growth rate until 2027. 
  • To classify and forecast Saudi Arabia over the counter (OTC) drugs market based on product, route of administration, dosage form, distribution channel, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the Saudi Arabia over the counter (OTC) drugs market.
  • To identify drivers and challenges for Saudi Arabia over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Saudi Arabia over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in Saudi Arabia over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in Saudi Arabia over the counter (OTC) drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of Saudi Arabia over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Over the counter (OTC) drugs manufacturers, end users, and other stakeholders
  • Distributers and suppliers of the products and other stakeholders
  • Organizations, forums, and alliances related to over the counter (OTC) drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Route of Administrations

·         Dosage Form

·         Distribution Channel

Regional scope

Northern & Central; Southern; Eastern; Western

Key companies profiled

Pfizer Saudi Limited, Sanofi Saudi Arabia, GlaxoSmithKline Saudi Arabia Limited, Gulf Pharmaceutical Industries (PSC), Tabuk Pharmaceutical Manufacturing Co., Jamjoom Pharmaceuticals Co, Reckitt Benckiser (Arabia) FZE, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO).

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Saudi Arabia over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Saudi Arabia Over the counter (OTC) Drugs Market, By Product:

o   Cough

o   Cold and Flu

o   Vitamins

o   Mineral, and Supplements (VMS)

o   Analgesics

o   Gastrointestinal Products

o   Dermatology Products

o   Others

  • Saudi Arabia Over the counter (OTC) Drugs Market, By Route of Administrations:
    • Oral
    • Topical
    • Parenteral
  • Saudi Arabia Over the counter (OTC) Drugs Market, By Dosage Form:
    • Tablets
    • Capsules
    • Liquids & Solution
    • Creams/Lotions/Ointments
    • Others
  • Saudi Arabia Over the counter (OTC) Drugs Market, By Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • Saudi Arabia Over the counter (OTC) Drugs Market, By Region:
    • Northern & Central
    • Southern
    • Eastern
    • Western

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Saudi Arabia over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Over the counter (OTC) Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Saudi Arabia Over-The-Counter (OTC) Drugs Drugs Market

4.    Executive Summary

5.    Voice of Customers

6.    Saudi Arabia Over-The-Counter (OTC) Drugs Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)

6.2.2.     By Route of Administration (Oral, Topical, Parenteral)

6.2.3.     By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    Saudi Arabia Cough, Cold and Flu Over-The-Counter (OTC) Drugs Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration

7.2.2.     By Dosage Form

7.2.3.     By Distribution Channel

8.    Saudi Arabia Vitamins, Mineral and Supplements (VMS) Over-The-Counter (OTC) Drugs Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Route of Administration

8.2.2.     By Dosage Form

8.2.3.     By Distribution Channel

9.    Saudi Arabia Analgesics Over-The-Counter (OTC) Drugs Drugs Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Route of Administration

9.2.2.     By Dosage Form

9.2.3.     By Distribution Channel

10.  Saudi Arabia Gastrointestinal Over-The-Counter (OTC) Drugs Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Route of Administration

10.2.2.  By Dosage Form

10.2.3.  By Distribution Channel

11.  Saudi Arabia Dermatology Over-The-Counter (OTC) Drugs Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Route of Administration

11.2.2.  By Dosage Form

11.2.3.  By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Policy & Regulatory Landscape

15.  Saudi Arabia Economic Profile

16.  Competitive Landscape

16.1.              Competition Outlook

16.2.              Company Profiles

16.2.1.  Pfizer Saudi Limited

16.2.2.  Sanofi Saudi Arabia

16.2.3.  GlaxoSmithKline Saudi Arabia Limited

16.2.4.  Gulf Pharmaceutical Industries (PSC)

16.2.5.  Tabuk Pharmaceutical Manufacturing Co.

16.2.6.  Jamjoom Pharmaceuticals Co

16.2.7.  Reckitt Benckiser (Arabia) FZE

16.2.8.  Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)

 17. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Factors like rapidly increasing concerns over the non-affordable branded pharmaceuticals is driving the growth of the Saudi Arabia over the counter (OTC) drugs market in the forecast years, 2023-2027.

down-arrow

Pfizer Saudi Limited, Sanofi Saudi Arabia, GlaxoSmithKline Saudi Arabia Limited, Gulf Pharmaceutical Industries (PSC), Tabuk Pharmaceutical Manufacturing Co., Jamjoom Pharmaceuticals Co, Reckitt Benckiser (Arabia) FZE, among others are leading the Saudi Arabia over the counter (OTC) drugs market in the forecast period, 2023-2027.

down-arrow

The Saudi Arabia over the counter (OTC) drugs market analysis was analyzed for the five historical years from 2017 to 2020. Keeping the base year 2020 as the margin, the estimation for the year 2022 was made and further market growth is predicted for the forecast years, 2023 to 2027.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

profile

Sakshi Bajaal

Business Consultant
Press Release

Saudi Arabia Over The Counter (OTC) Drugs Market to Grow Due to Technological Advancement until 2026

Aug, 2021

Surging demand for OTC drugs is driving the growth of Saudi Arabia Over the counter (OTC) Drugs Market, in the forecast period, 2022-2026.